Hepatitis Monthly

Published by: Kowsar

Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study

Milad Azami 1 , Mohammad Reza Hafezi Ahmadi 2 and Kourosh Sayehmiri 3 , *
Authors Information
1 Medical Student, Student Research Committee, Ilam University of Medical Sciences, Ilam, IR Iran
2 Associate Professor, Department of Pathology, Faculty of Medicine, Ilam University of Medical Sciences , Ilam, IR Iran
3 Associate Professor, Department of Biostatistics, Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, IR Iran
Article information
  • Hepatitis Monthly: January 01, 2017, 17 (1); e37781
  • Published Online: December 18, 2016
  • Article Type: Review Article
  • Received: March 12, 2016
  • Revised: May 31, 2016
  • Accepted: December 10, 2016
  • DOI: 10.5812/hepatmon.37781

To Cite: Azami M, Hafezi Ahmadi M R, Sayehmiri K. Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study, Hepat Mon. 2017 ; 17(1):e37781. doi: 10.5812/hepatmon.37781.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Data Sources
4. Data Extraction
5. Results
6. Discussion
  • 1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373(9663): 582-92[DOI][PubMed]
  • 2. Rodriguez-Frias F, Buti M, Tabernero D, Homs M. Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach. World J Gastroenterol. 2013; 19(41): 6995-7023[DOI][PubMed]
  • 3. Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris). 2010; 58(4): 288-95[DOI][PubMed]
  • 4. Sayehmiri K, Azami M, Borji M, Nikpay S, Chamani M. Seroprevalence of Hepatitis B Virus Surface Antigen (HBsAg) in Iranian Health Care Workers: Systematic Review and Meta-Analysis Study. Occupational and Environmental Health. 2016; 2(1): 47-57
  • 5. Saltoglu N, Inal AS, Tasova Y, Kandemir O. Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrob. 2003; 2: 10[DOI][PubMed]
  • 6. Habibzadeh S, Yazdanband A, Amani F, Rajabi R. Evaluation of response to hepatitis B vaccine in hospital nursing staff, Bu-Ali-Ali Asghar (dissertation). 2004;
  • 7. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, et al. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine. 1999; 17(20-21): 2661-6[DOI]
  • 8. Sayehmiri K, Azami M, Nikpey S, Borji M, Sayehmiri F. Hepatitis B Vaccination Coverage in Health Personnel of Iran: A Systematic Review and Meta-Analysis Study. Iran J Epidemiol. 2015; 11(3): 1-10
  • 9. Azami M, Borji M, Ghanbari F, Nikpay S, Sayehmiri K. Hepatitis B vaccination coverage of physicians and nurses in Iran: a systematic review and meta-analysis study. J Birjand Univ Med Sci. 2015; 22(4): 304-15
  • 10. Azami M, Sayehmiri K, Darvishi Z, Sayehmiri F. Hepatitis B vaccination coverage among dentists in Iran: a systematic review and meta-analysis study. Hepat Mon. 2015; 15(83): 37
  • 11. Bonanni P, Pesavento G, Boccalini S, Bechini A. Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B. J Hepatol. 2003; 39 Suppl 1-9[PubMed]
  • 12. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002; 35(11): 1368-75[DOI][PubMed]
  • 13. Mokhtarian K, Yazdanparast M, Tarshizi R, Moghani M. Evaluation levels of antibodies against hepatitis B in staffs of Hajar Hospital, 2007-2008. J ShahrekordUniv Med Sci . 2009; 11: 35-9
  • 14. Zangeneh M, Valikhani MD. Evaluation of immunogenicity of hepatitis B vaccination in health workers. Med Sci J Islamic Azad Univ Tehran Med Branch. 2004; 14(1): 13-22
  • 15. Kashifar M, Hasanjaniroshan MR. Response to hepatitis B vaccination in hospital personnel Yahyanejad 2002 . J BabolUniv Med Sci. 2004; 6: 39-42
  • 16. Janbakhsh A, Vaziri S, Sayad B, Afsharian M, Rezaei M, Montazeripour H. Immune response to standard dose of hepatitis B vaccine in HIV positive clients of Kermanshah behavioral diseases counseling center. Hepat Mon. 2006; 2006(2, Spring): 71-4
  • 17. Talebi Taher M, Akbari M, Rezaee M, Ashaerii N, Omrani Z, Ghaderian H, et al. Determination of anti-HBS titre mean induced by hepatitis B vaccine among health care workers in Firoozgar hospital in Tehran. Razi J Med Sci. 2004; 11(43): 789-95
  • 18. Taghavi N, Eilami O, Nabavi M, Azargashb E, Yadegarynia D, Alizadeh AM. Immunogenicity of recombinant hepatitis B vaccine in health care worker of Boo-Ali hospital in Tehran, Iran, 2002-2004. Arch Clin Infect Dis. 2006; 1(2)
  • 19. Mohsenzade M, Pirouzi A, Jafari M, Azadi M, Raeiszadeh-Jahromi S, Afkari, R. . Study on the Serum Titer of Anti-HBs Antibody of the Vaccinated Staffs of a Hospital in Three Consecutive Years. Zahedan J Res Med Sci. 2013; 15(12): 23-7
  • 20. Bayani M, Siadati S, Hajiahmadi M, Khani A, Naemi N. Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran. Iran J Pathol. 2014; 9(3): 187-92
  • 21. Baghianimoghadam MH, Shadkam MN, Hadinedoushan H. Immunity to hepatitis B vaccine among health care workers. Vaccine. 2011; 29(15): 2727-9[DOI][PubMed]
  • 22. Rezaei A, Vaez SA. Evaluation of the immunogenicity of Hepatitis B vaccine in students of the Isfahan University of Medical Sciences. J Res Med Sci. 1999; 4(1): 11-7
  • 23. Abediyan F, Ajami A. Immunogenecity of hepatitis B vaccine in Mazandaran medical sciences students-2004. Urmia Med J. 2006; 9(1-2): 17-1
  • 24. Ajami A, Abediyan F. Immunogenecity of hepatitis B vaccine in Mazandaran medical sciences students-2004. J Mazandaran Univ Med Sci. 2006; 16(53): 72-7
  • 25. Nashibi R, Alavi SM, Yousefi F, Salmanzadeh S, Moogahi S, Ahmadi F, et al. Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff. Jundishapur J Microbiol. 2015; 8(3)[DOI][PubMed]
  • 26. Khodaveisi M, Mohammadi N, Omidi A, Amini R. Antibody Titers of Hepatitis B in Hamadan's Nursing and Midwifery Students. Sci J Hamadan Nurs Midwifery Faculty. 2010; 18(1): 45-55
  • 27. Varshochi M, Shahi JM. Management of non-responder health care workers to hepatitis B routine vaccination 1. Life Sci J. 2012; 9(4): 4551-4
  • 28. Abdolsamadi HR, Vaziri PB, Abdollahzadeh SH, Kashani KHM, Vahedi M. Immune response to hepatitis B vaccine among dental students. Iran J Public Health. 2009; 38(2): 113-8
  • 29. Sarkari B, Zargar MA, Mohammad R, Asgarian SH. Prevalence of hepatitis B antibodies in health-care workers in Yasuj hospitals. Armaghane Danesh. 2007; 11(4): 97-106
  • 30. Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, et al. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine. Human Vaccines. 2014; 6(2): 212-8[DOI]
  • 31. Azizi F, Malekzade R, Janghorbani M, Hatami H. Epidemiology and control of the common diseases in Iran. 2001; : 714-42
  • 32. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000; 3(4): 192-201
  • 33. Sherlock S, Dooley J. Hepatitis B virus and hepatitis delta virus. Diseases of the Liver and Biliary System. 2002; : 285-300
  • 34. Ayerbe MC, Perez-Rivilla A, Icovahb group . Assessment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol. 2001; 17(2): 150-6[PubMed]
  • 35. Spector TD, Thompson SG. The potential and limitations of meta-analysis. J Epidemiol Community Health. 1991; 45(2): 89-92[PubMed]
  • 36. Azami M, Khataee M, Bigam bigdeli-shamlo M, Abasalizadeh F, Abasalizadeh Sh, et al. Prevalence and Risk Factors of Hepatitis B Infection in Pregnant Women of Iran: A Systematic Review and Meta-Analysis. IJOGI. 2016; 19(18): 17-30
  • 37. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; 151(4)-94[PubMed]
  • 38. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007; 4(10)[DOI][PubMed]
  • 39. Azami M, Sayehmiri K. Prevalence of Diabetes Mellitus in Iranian Patients with Thalassemia Major: A Systematic Review and Meta-Analysis. J Mazandaran Univ Med Sci. 2016; 26(141): 192-204
  • 40. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010; 1(2): 97-111[DOI][PubMed]
  • 41. Thakur V, Pati NT, Gupta RC, Sarin SK. Efficacy of Shanvac-B recombinant DNA hepatitis B vaccine in health care workers of Northern India. Hepatobiliary Pancreat Dis Int. 2010; 9(4): 393-7[PubMed]
  • 42. Beran J, Van Der Meeren O, Leyssen M, D'Silva P. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine. Vaccine. 2016; 34(24): 2686-91[DOI][PubMed]
  • 43. Thomas RJ, Fletcher GJ, Kirupakaran H, Chacko MP, Thenmozhi S, Eapen CE, et al. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital. Indian J Med Microbiol. 2015; 33 Suppl: 32-6[DOI][PubMed]
  • 44. Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis. 2013; 17(11)-9[DOI][PubMed]
  • 45. Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int. 2005; 25(6): 1162-8[DOI][PubMed]
  • 46. Wang ZZ, Li MQ, Wang P, Yang ZX, Wei L, Zeng Y, et al. Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China. Vaccine. 2016; 34(8): 1034-9[DOI][PubMed]
  • 47. Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev. 2005; (4)[DOI][PubMed]
  • 48. Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study. Hepat Mon. 2015; 15(5)[DOI][PubMed]
  • 49. Park K. Text Book of Preventive and Social Medicine. 2002; : 113-21
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments